Buscojobs
Corporate Development Director (Hybrid, 3-Days In Palo Alto, Ca Office)
Buscojobs, California, Missouri, United States, 65018
Corporate Development Director (Hybrid, 3-Days in Palo Alto, CA Office)
Guardant Health is the leading precision oncology company with a dedication to conquering cancer globally. The Company was the first to develop proprietary genomics tests utilizing vast data sets and advanced analytics to find and characterize the basis of cancer in each patient individually. The Company operates through two unique platforms: Oncology and Screening. The Oncology platform generates over $600 million in revenue by improving patient clinical outcomes and lowers healthcare costs across all stages of the cancer care continuum via its unique genomic and epigenomic sequencing capabilities. Oncology products include Guardant360, Guardant360 CDx, Guardant360 TissueNext, Guardant360 Response, and GuardantOMNI tests for advanced stage cancer patients, and Guardant Reveal for earlier-stage cancer patients. The Screening portfolio includes the recently FDA approved next generation sequencing based Shield test to screen the population for Colorectal cancer. Guardant Health Corporate Development is an elite, small group of individuals within Guardant Health. The group is responsible for license, partnership and acquisition strategy development and execution, long range planning / strategy, and business intelligence insights. The group operates through advisement to the Guardant Health Investment Committee in order to set and execute traditional M&A, partnership and investment strategies. About the Role The Corporate Development Director is responsible for supporting the Corporate Development function for Guardant Health. The role will be integral in all group functional capacities and requires a self-starter familiar with the capital markets, strategy, valuation, and financial analysis. An ability to understand the basics of genomics is helpful to succeed. The candidate will help proactively shape Guardant’s corporate development strategy by identifying industry trends, maintaining relationships with relevant external partners, as well as sourcing, negotiating, structuring, and executing strategic acquisitions/investments across all of the Company’s geographies and businesses. This role will require extreme competency and adaptability as group priorities change in response to the ever-changing competitive environment for M&A. Essential Duties and Responsibilities: Lead the transaction due diligence process Develop business cases supported by market, valuation and financial analytics Support the Company’s growth strategy through identification, assessment and execution of potential M&A, investments and partnerships. Support a robust and comprehensive process to identify and evaluate potential opportunities, which includes a rigorous idea generation and screening process that will bring quality acquisition and investment ideas to the Company’s executive management team Collaborate with leaders to think about corporate development opportunities in a progressive, systematic and routine fashion. Partner with business leaders before, during and after the M&A processes to ensure the deals make strategic sense and are integrated smoothly. Support cross-functional teams in developing acquisition business case analyses and executing and interfacing with Finance, Accounting, Legal, Tax, HR and other departments of the Company to ensure seamless due diligence and deal execution Essential Qualifications: 10+ years of experience in Corporate Development or M&A at a comparable healthcare company or Investment Bank. Experience in Product, R&D, or Marketing a plus Undergraduate business degree, MBA or PhD degree with a technical background in genomics, therapeutics, or oncology preferred M&A partnering and equity investment experience, including negotiation, thorough execution, and transaction closing Intermediate or advanced understanding of the biotech, diagnostic, or medical device industry Superior analytical and problem-solving skills Ability to structure and manage complex projects and processes with multiple stakeholders at all levels Excellent presentation skills, including strong oral and writing capabilities Ability to travel, both domestically and internationally, 10% - 20% to conferences and meetings Hybrid Work Model
: At Guardant Health, we have defined days for in-person/onsite collaboration and work-from-home days for individual-focused time. All U.S. employees who live within 50 miles of a Guardant facility will be required to be onsite on Mondays, Tuesdays, and Thursdays. Guardant Health is committed to providing reasonable accommodations in our hiring processes for candidates with disabilities, long-term conditions, mental health conditions, or sincerely held religious beliefs. Guardant Health is an Equal Opportunity Employer. All qualified applicants will receive consideration for employment without regard to race, color, religion, sex, sexual orientation, gender identity, national origin, or protected veteran status and will not be discriminated against on the basis of disability.
#J-18808-Ljbffr
Guardant Health is the leading precision oncology company with a dedication to conquering cancer globally. The Company was the first to develop proprietary genomics tests utilizing vast data sets and advanced analytics to find and characterize the basis of cancer in each patient individually. The Company operates through two unique platforms: Oncology and Screening. The Oncology platform generates over $600 million in revenue by improving patient clinical outcomes and lowers healthcare costs across all stages of the cancer care continuum via its unique genomic and epigenomic sequencing capabilities. Oncology products include Guardant360, Guardant360 CDx, Guardant360 TissueNext, Guardant360 Response, and GuardantOMNI tests for advanced stage cancer patients, and Guardant Reveal for earlier-stage cancer patients. The Screening portfolio includes the recently FDA approved next generation sequencing based Shield test to screen the population for Colorectal cancer. Guardant Health Corporate Development is an elite, small group of individuals within Guardant Health. The group is responsible for license, partnership and acquisition strategy development and execution, long range planning / strategy, and business intelligence insights. The group operates through advisement to the Guardant Health Investment Committee in order to set and execute traditional M&A, partnership and investment strategies. About the Role The Corporate Development Director is responsible for supporting the Corporate Development function for Guardant Health. The role will be integral in all group functional capacities and requires a self-starter familiar with the capital markets, strategy, valuation, and financial analysis. An ability to understand the basics of genomics is helpful to succeed. The candidate will help proactively shape Guardant’s corporate development strategy by identifying industry trends, maintaining relationships with relevant external partners, as well as sourcing, negotiating, structuring, and executing strategic acquisitions/investments across all of the Company’s geographies and businesses. This role will require extreme competency and adaptability as group priorities change in response to the ever-changing competitive environment for M&A. Essential Duties and Responsibilities: Lead the transaction due diligence process Develop business cases supported by market, valuation and financial analytics Support the Company’s growth strategy through identification, assessment and execution of potential M&A, investments and partnerships. Support a robust and comprehensive process to identify and evaluate potential opportunities, which includes a rigorous idea generation and screening process that will bring quality acquisition and investment ideas to the Company’s executive management team Collaborate with leaders to think about corporate development opportunities in a progressive, systematic and routine fashion. Partner with business leaders before, during and after the M&A processes to ensure the deals make strategic sense and are integrated smoothly. Support cross-functional teams in developing acquisition business case analyses and executing and interfacing with Finance, Accounting, Legal, Tax, HR and other departments of the Company to ensure seamless due diligence and deal execution Essential Qualifications: 10+ years of experience in Corporate Development or M&A at a comparable healthcare company or Investment Bank. Experience in Product, R&D, or Marketing a plus Undergraduate business degree, MBA or PhD degree with a technical background in genomics, therapeutics, or oncology preferred M&A partnering and equity investment experience, including negotiation, thorough execution, and transaction closing Intermediate or advanced understanding of the biotech, diagnostic, or medical device industry Superior analytical and problem-solving skills Ability to structure and manage complex projects and processes with multiple stakeholders at all levels Excellent presentation skills, including strong oral and writing capabilities Ability to travel, both domestically and internationally, 10% - 20% to conferences and meetings Hybrid Work Model
: At Guardant Health, we have defined days for in-person/onsite collaboration and work-from-home days for individual-focused time. All U.S. employees who live within 50 miles of a Guardant facility will be required to be onsite on Mondays, Tuesdays, and Thursdays. Guardant Health is committed to providing reasonable accommodations in our hiring processes for candidates with disabilities, long-term conditions, mental health conditions, or sincerely held religious beliefs. Guardant Health is an Equal Opportunity Employer. All qualified applicants will receive consideration for employment without regard to race, color, religion, sex, sexual orientation, gender identity, national origin, or protected veteran status and will not be discriminated against on the basis of disability.
#J-18808-Ljbffr